While these studies underscore the role of FOXP3+ T cells in the evolution of DCIS, the low frequency of these cells in DCIS (<10% of all T cells) and their highly variable topological distribution make quantitative assessment and immune scoring a challenging task8. Here, FOXP3 is linked to ductal breast carcinoma in situ.